Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 10, keine Gesamtzahl für „Ellipta“
Suchtreffer
Begriffe & Kennungen
Relvar Ellipta · 4.8 · Data from large asthma and COPD clinical trials were used to determine the frequency of adverse reactions asso
Eintrag öffnenRelvar Ellipta · 4.8 · Description of selected adverse reactions
Eintrag öffnenRelvar Ellipta · 4.8 · Description of selected adverse reactions
Eintrag öffnenRelvar Ellipta · 4.8 · For the SUMMIT study, the incidence of all events of fracture with FF/VI, FF, VI and placebo were 2% in each a
Eintrag öffnenRelvar Ellipta · 4.8 · For the SUMMIT study, the incidence of all events of fracture with FF/VI, FF, VI and placebo were 2% in each a
Eintrag öffnenRelvar Ellipta · 4.8 · In a placebo-controlled study (SUMMIT) in subjects with moderate COPD (mean percent post- bronchodilator scree
Eintrag öffnenRelvar Ellipta · 4.8 · In a placebo-controlled study (SUMMIT) in subjects with moderate COPD (mean percent post- bronchodilator scree
Eintrag öffnenRelvar Ellipta · 4.8 · In an integrated analysis of 11 studies in asthma (7,034 patients), the incidence of pneumonia per 1000 patien
Eintrag öffnenRelvar Ellipta · 4.8 · In an integrated analysis of 11 studies in asthma (7,034 patients), the incidence of pneumonia per 1000 patien
Eintrag öffnenRelvar Ellipta · 4.8 · In an integrated analysis of the two replicate one year studies in moderate to severe COPD (mean predicted pos
Eintrag öffnenRelvar Ellipta · 4.8 · In an integrated analysis of the two replicate one year studies in moderate to severe COPD (mean predicted pos
Eintrag öffnenRelvar Ellipta · 4.8 · In two replicate 12 month studies in a total of 3,255 patients with COPD the incidence of bone fractures overa
Eintrag öffnenRelvar Ellipta · 4.8 · In two replicate 12 month studies in a total of 3,255 patients with COPD the incidence of bone fractures overa
Eintrag öffnenRelvar Ellipta · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenRelvar Ellipta · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenRelvar Ellipta · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenRelvar Ellipta · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenRelvar Ellipta · 4.8 · Summary of the safety profile
Eintrag öffnenRelvar Ellipta · 4.8 · Summary of the safety profile
Eintrag öffnenRelvar Ellipta · 4.8 · System organ class Adverse reaction(s) Frequency Infections and infestations Pneumonia* Common Upper respirato
Eintrag öffnen